Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Mayo Clinic
Sichuan Enray Pharmaceutical Sciences Company
University of Colorado, Denver
Karolinska University Hospital
Medical College of Wisconsin
Mayo Clinic
University of Pittsburgh
M.D. Anderson Cancer Center
University of Arizona
Washington University School of Medicine
Institut Claudius Regaud
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Cancer Research UK
Sichuan Enray Pharmaceutical Sciences Company
The Netherlands Cancer Institute
University of Virginia
Cancer Research UK
N.N. Petrov National Medical Research Center of Oncology
Arbeitsgemeinschaft medikamentoese Tumortherapie
Rutgers, The State University of New Jersey
Vall d'Hebron Institute of Oncology
Cancer Research UK
Second Affiliated Hospital of Guangzhou Medical University
Beijing Friendship Hospital
Sun Yat-sen University
University of Florida
Umeå University
Massachusetts General Hospital
Barbara Ann Karmanos Cancer Institute
Guangzhou Women and Children's Medical Center
Kazakh Medical University of Continuing Education
Augusta University
Shanghai Fengxian District Central Hospital
Wake Forest University Health Sciences
Rutgers, The State University of New Jersey
Albert Einstein College of Medicine
Rigshospitalet, Denmark
M.D. Anderson Cancer Center
Ciusss de L'Est de l'Île de Montréal
Abramson Cancer Center at Penn Medicine
Cambridge University Hospitals NHS Foundation Trust
City of Hope Medical Center
Beth Israel Medical Center
CureOne
Johns Hopkins University
Shandong Cancer Hospital and Institute